drugset / Trial / NCT03587285
A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer
Phase 1/2
Unknown
11 enrolled
Guangzhou University of Traditional Chinese Medicine
Chinese Academy of Medical Sciences · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the feasibility, safety and oncological efficacy of hormonal therapy combined with autologous Tcm cells for patients with advanced prostate cancer.
Timeline
- Start
- 2018-09-23
- Primary completion
- 2021-07-30
- Completion
- 2021-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | 1000 mg | Oral |
| Subject | Bicalutamide | Other / unclassified | 50 mg | Oral |
| Subject | Tcm cells | Cell therapy | — | Intravenous |
| Background | Goserelin | Other / unclassified | 3.6 mg | Subcutaneous |
| Background | Prednisone | Other / unclassified | 5 mg | Oral |